Overview

Next-Generation Sequencing (NGS) Market Introduction:

Next Generation Sequencing (NGS) Sample Preparation Market is anticipated to value over USD 3.2 billion with a CAGR of over 17% during the forecast period 2020-2027.

Genetics has a large scope in current as well as future research and development. Next generation sequencing (NGS) is a rapidly growing stream in genetic research. It's a parallel sequencing method used to make a whole human genome rapidly. The functional annotations in genetic mutations have become easy with NGS projects.

The NGS sample preparation market has a wide scope currently and in the future also. The recent studies and research on NGS sample preparation is the key factor driving its market growth. The different research organizations get funds for their NGS sample preparation projects by both government and non-government bodies.

The library preparation and target enrichment get more focus as compared to other product types of the market. To improve the recent traditional diagnostic and treatment methods both play a key role. Target enrichment provides patient compliance in case cancer and tumour treatments as the affected area is targeted directly with reduced harm to other organs.

Drug discovery in NGS sample preparation is a major sector as it gets massive funds and demand in the market. Various biomarkers, DNA fragments can be used for discovering new drugs. Also because of such extensive market demand, the research and diagnostic centres also play a key role in driving market growth.

North America, Europe and Asia Pacific are dominating regions in global NGS sample preparation market. The rising genetic disorders and patient population along with awareness and the research developments, these regions are anticipated to have a large market share.

Key players in the market are:
Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter (A Subsidiary of Danaher) F. Hoffmann-La Roche AG, Illumina, Inc., New England Biolabs, Inc., Nugen Technologies, Inc. (Part of Tecan Trading Ag), Oxford Gene Technology (Part of Sysmex), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., Perkinelmer, Inc., QIAGEN N.V., Raindance Technologies, Inc. (Part of Bio-Rad Laboratories), Swift Biosciences Inc., Thermo Fisher Scientific Inc..

Agilent Technologies is anticipated to have a major market share. It has a range of advanced NGS assays for diagnosis of cancer, target enrichment probes, NGS software, NGS quality control, and so on. The availability of these facilities by Agilent Technologies is the key factor driving its market growth in NGS sample preparation across the globe.

Next Generation Sequencing (NGS) Sample Preparation Market

Next Generation Sequencing (NGS) Sample Preparation Market Segmentation:

By Product

Workstations
Reagents & Consumables

By Workflow

Library Preparation
DNA
Human Whole Genome Sequencing (WGS)
Targeted Sequencing
Whole Exome Sequencing (WES)
Others
RNA
Gene Expression Analysis
Whole Transcriptome Sequencing
Others
Target Enrichment
Targeted Seq
WES
Others
Quality Control

By Technology

Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-molecule Real-time (SMRT) Sequencing
Nanopore Sequencing
Other Technologies

By End User

Academic Institutes and Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users (Includes non-profit organizations, agrigenomics organizations, reference laboratories, and consumer genomics companies, among others)

By Application

Disease Diagnostics
Cancer Diagnostics
Reproductive Health Diagnostics
Infectious Disease Diagnostics
Other Disease Diagnostic Applications
Drug Discovery
Agricultural and Animal Research
Other Applications

By Region

North America
Latin America
Europe
Asia-Pacific
Middle East and Africa

Competitive Landscape:

Agilent Technologies has provided NGS assays for the detection of somatic cancer and is expected to be the key factos
Agilent Technologies has a target enrichment probe that targets 151 key genes associated with a wide range of cancers

FutureWise Key Takeaways:

Drug discovery based on NGS sample preparation
More focus on target enrichment techniques

Objectives of the Study:

To provide with an exhaustive analysis on the next generation sequencing (NGS) sample preparation market by products, by applications, by end user and by region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and the rest of the world.
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com